Published in Pharmacol Ther on August 29, 2012
Using conditioned place preference to identify relapse prevention medications. Neurosci Biobehav Rev (2013) 0.91
A new approach to assess gambling-like behavior in laboratory rats: using intracranial self-stimulation as a positive reinforcer. Front Behav Neurosci (2014) 0.83
Methylphenidate vs. resperidone in treatment of methamphetamine dependence: A clinical trial. Saudi Pharm J (2013) 0.77
Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry (2016) 0.76
A Review of the Literature of Mirtazapine in Co-Occurring Depression and an Alcohol Use Disorder. J Addict Behav Ther Rehabil (2016) 0.75
Mirtazapine-induced acute angle closure. Indian J Ophthalmol (2015) 0.75
Neurocircuitry of addiction. Neuropsychopharmacology (2010) 14.22
Separate neural systems value immediate and delayed monetary rewards. Science (2004) 13.85
The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry (2005) 12.53
Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat Neurosci (2005) 7.65
Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers. Psychopharmacology (Berl) (1999) 7.04
Limbic activation during cue-induced cocaine craving. Am J Psychiatry (1999) 6.66
Toward a behavioral economic understanding of drug dependence: delay discounting processes. Addiction (2001) 6.18
Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci (2006) 5.69
Impulsive and self-control choices in opioid-dependent patients and non-drug-using control participants: drug and monetary rewards. Exp Clin Psychopharmacol (1997) 5.32
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci (2011) 4.88
Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci U S A (1996) 4.31
Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol (1998) 3.70
Conditioning factors in drug abuse: can they explain compulsion? J Psychopharmacol (1998) 3.65
Behavioral and neuroeconomics of drug addiction: competing neural systems and temporal discounting processes. Drug Alcohol Depend (2006) 3.26
Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron (2002) 3.06
Pharmacokinetics and bioavailability of zidovudine in humans. Am J Med (1988) 2.80
SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr (2005) 2.71
Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes. J Pharmacol Exp Ther (1996) 2.43
Congruence of BOLD response across intertemporal choice conditions: fictive and real money gains and losses. J Neurosci (2009) 2.18
Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci (2003) 2.08
Neurocognitive deficits in cocaine users: a quantitative review of the evidence. J Clin Exp Neuropsychol (2005) 2.05
Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Clin Ther (2008) 1.95
Medications development: successes and challenges. Pharmacol Ther (2005) 1.80
Tricyclic antidepressant poisoning : cardiovascular toxicity. Toxicol Rev (2005) 1.70
Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues. Neuroimage (2007) 1.66
Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors. J Neurochem (2000) 1.64
RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology (2001) 1.62
Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse. Prog Brain Res (2008) 1.62
Pharmacokinetics, absolute bioavailability, and absorption characteristics of lamivudine. J Clin Pharmacol (1995) 1.60
Critical assessment of how to study addiction and its treatment: human and non-human animal models. Pharmacol Ther (2005) 1.59
How stress and fluoxetine modulate serotonin 2C receptor pre-mRNA editing. J Neurosci (2005) 1.57
Whole-cell plasticity in cocaine withdrawal: reduced sodium currents in nucleus accumbens neurons. J Neurosci (1998) 1.50
Similar neurons, opposite adaptations: psychostimulant experience differentially alters firing properties in accumbens core versus shell. J Neurosci (2009) 1.50
Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology (2002) 1.49
Functional correlates of serotonin 5-HT1 recognition sites. J Recept Res (1988) 1.48
SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology (1999) 1.46
RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia. Mol Psychiatry (2001) 1.45
Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. J Neurosci (2004) 1.39
RNA editing of the serotonin 5HT2C receptor and its effects on cell signalling, pharmacology and brain function. Pharmacol Ther (2008) 1.36
Exposure to cocaine dynamically regulates the intrinsic membrane excitability of nucleus accumbens neurons. J Neurosci (2010) 1.36
Predictors of relapse after treatment for methamphetamine use. J Psychoactive Drugs (2000) 1.34
The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues. Neuropsychopharmacology (2007) 1.32
The pharmacologic profile of mirtazapine. J Clin Psychiatry (1996) 1.22
Increased serotonin 2C receptor mRNA editing: a possible risk factor for suicide. Mol Psychiatry (2007) 1.22
Human immunodeficiency virus-associated neurocognitive disorder: pathophysiology in relation to drug addiction. Ann N Y Acad Sci (2010) 1.22
Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior. J Pharmacol Exp Ther (2000) 1.21
Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats. Behav Pharmacol (2007) 1.20
Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model. Behav Neurosci (2009) 1.20
Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence. Curr Top Med Chem (2006) 1.19
Distribution of serotonin 5-HT2C receptors in the ventral tegmental area. Neuroscience (2007) 1.16
Modulation of dopamine release by striatal 5-HT2C receptors. Synapse (2005) 1.16
Serotonin2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addiction. Neuroscience (2007) 1.16
Mirtazapine to reduce methamphetamine use: a randomized controlled trial. Arch Gen Psychiatry (2011) 1.16
Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions. Ann Clin Psychiatry (2008) 1.14
Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual. J Subst Abuse Treat (2008) 1.13
A review of the pharmacokinetics of abacavir. Clin Pharmacokinet (2008) 1.12
Stimulation of medial prefrontal cortex serotonin 2C (5-HT(2C)) receptors attenuates cocaine-seeking behavior. Neuropsychopharmacology (2010) 1.12
Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction. Mol Pharmacol (2007) 1.10
Cocaine self-administration reduces excitatory responses in the mouse nucleus accumbens shell. Neuropsychopharmacology (2005) 1.09
Contingency management: utility in the treatment of drug abuse disorders. Clin Pharmacol Ther (2008) 1.08
Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions. Curr Drug Metab (2008) 1.08
Effects of chronic administration of drugs of abuse on impulsive choice (delay discounting) in animal models. Behav Pharmacol (2009) 1.07
The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine. Br J Clin Pharmacol (1997) 1.05
Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention. Drug Alcohol Rev (2007) 1.04
Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum. J Neurochem (2000) 1.04
Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses. J Pharmacol Exp Ther (2004) 1.03
5-HT(2C) receptors localize to dopamine and GABA neurons in the rat mesoaccumbens pathway. PLoS One (2011) 1.03
Identification and characterization of RNA editing events within the 5-HT2C receptor. Ann N Y Acad Sci (1998) 1.03
Clinical pharmacokinetics of mirtazapine. Clin Pharmacokinet (2000) 1.03
Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: a multicentre, open label study. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.02
Serotonergic mechanisms in addiction-related memories. Behav Brain Res (2008) 1.01
Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes. Curr Opin Investig Drugs (2006) 1.00
Neurotoxicity and neurocognitive impairments with alcohol and drug-use disorders: potential roles in addiction and recovery. Alcohol Clin Exp Res (2001) 0.99
Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors. J Neurochem (2006) 0.99
Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex. Eur J Pharmacol (2004) 0.99
Pharmacology of antidepressants: selectivity or multiplicity? J Clin Psychiatry (1999) 0.98
Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers. Neuropharmacology (1988) 0.97
Antidepressants for cocaine dependence. Cochrane Database Syst Rev (2003) 0.97
Expression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei. J Chem Neuroanat (2005) 0.96
Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation. Brain Res Bull (2004) 0.96
Serotonin2C receptors (5-HT2C R) control expression of cocaine-induced conditioned hyperactivity. Drug Alcohol Depend (2005) 0.95
The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists. Psychopharmacology (Berl) (2006) 0.95
A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal. Drug Alcohol Rev (2008) 0.95
Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study. Hum Psychopharmacol (2008) 0.95
Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation. J Neurochem (1999) 0.94
Contribution of serotonin (5-HT) 5-HT2 receptor subtypes to the discriminative stimulus effects of cocaine in rats. Psychopharmacology (Berl) (2005) 0.91
Mirtazapine alters cue-associated methamphetamine seeking in rats. Biol Psychiatry (2010) 0.91
Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification. Prog Neuropsychopharmacol Biol Psychiatry (2004) 0.90
Regional distribution and relative abundance of serotonin(2c) receptors in human brain: effect of suicide. Neurochem Res (2006) 0.90
Altered serotonin 2C receptor RNA splicing in suicide: association with editing. Neuroreport (2008) 0.89
Do some antidepressants work faster than others? J Clin Psychiatry (2001) 0.89
Ondansetron given in the acute withdrawal from a repeated cocaine sensitization dosing regimen reverses the expression of sensitization and inhibits self-administration. Neuropsychopharmacology (2002) 0.89
Mirtazapine treatment after conditioning with methamphetamine alters subsequent expression of place preference. Drug Alcohol Depend (2008) 0.88
Constitutive activity of serotonin 2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants. Mol Pharmacol (2010) 0.88
Nullifying drug-induced sensitization: behavioral and electrophysiological evaluations of dopaminergic and serotonergic ligands in methamphetamine-sensitized rats. Drug Alcohol Depend (2006) 0.87
SB 206553, a putative 5-HT2C inverse agonist, attenuates methamphetamine-seeking in rats. BMC Neurosci (2012) 0.87
Role of serotonin (5-HT)2 receptors in cocaine self-administration and seeking behavior in rats. Pharmacol Rep (2005) 0.87
Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission. J Affect Disord (1998) 0.86
Active beta-catenin signaling is an inhibitory pathway for human immunodeficiency virus replication in peripheral blood mononuclear cells. J Virol (2008) 1.18
Aminophylline in bradyasystolic cardiac arrest: a randomised placebo-controlled trial. Lancet (2006) 1.15
Amphetamine-induced place preference and conditioned motor sensitization requires activation of tyrosine kinase receptors in the hippocampus. J Neurosci (2006) 1.13
Methamphetamine-induced sensitization differentially alters pCREB and DeltaFosB throughout the limbic circuit of the mammalian brain. Mol Pharmacol (2006) 1.11
The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation. Front Pharmacol (2012) 1.07
The neural substrates of amphetamine conditioned place preference: implications for the formation of conditioned stimulus-reward associations. Eur J Neurosci (2006) 1.01
The ventral pallidum is critically involved in the development and expression of morphine-induced sensitization. Neuropsychopharmacology (2008) 1.01
Corticosteroid induced psychosis in the pain management setting. Pain Physician (2008) 0.98
Surrogate decision makers for incompetent ICU patients: a European perspective. Curr Opin Crit Care (2008) 0.96
Changes in accumbal and pallidal pCREB and deltaFosB in morphine-sensitized rats: correlations with receptor-evoked electrophysiological measures in the ventral pallidum. Neuropsychopharmacology (2006) 0.93
Context modulates the expression of conditioned motor sensitization, cellular activation and synaptophysin immunoreactivity. Eur J Neurosci (2007) 0.91
Cortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaine. Curr HIV Res (2015) 0.91
Mirtazapine alters cue-associated methamphetamine seeking in rats. Biol Psychiatry (2010) 0.91
Pramipexole-induced increased probabilistic discounting: comparison between a rodent model of Parkinson's disease and controls. Neuropsychopharmacology (2012) 0.89
Mirtazapine treatment after conditioning with methamphetamine alters subsequent expression of place preference. Drug Alcohol Depend (2008) 0.88
Emerging, reemerging, and forgotten brain areas of the reward circuit: Notes from the 2010 Motivational Neural Networks conference. Behav Brain Res (2011) 0.88
Methamphetamine-induced vascular changes lead to striatal hypoxia and dopamine reduction. Neuroreport (2011) 0.88
SB 206553, a putative 5-HT2C inverse agonist, attenuates methamphetamine-seeking in rats. BMC Neurosci (2012) 0.87
Enduring cortical alterations after a single in-vivo treatment of HIV-1 Tat. Neuroreport (2012) 0.87
Mu and kappa opioid agonists modulate ventral tegmental area input to the ventral pallidum. Eur J Neurosci (2002) 0.86
Brain region-selective cellular redistribution of mGlu5 but not GABA(B) receptors following methamphetamine-induced associative learning. Synapse (2011) 0.86
Intra-ventral pallidal glutamate antagonists block expression of morphine-induced place preference. Behav Neurosci (2006) 0.85
Repeated exposure to morphine alters surface expression of AMPA receptors in the rat medial prefrontal cortex. Eur J Neurosci (2010) 0.85
Methamphetamine and HIV-1 Tat down regulate β-catenin signaling: implications for methampetamine abuse and HIV-1 co-morbidity. J Neuroimmune Pharmacol (2011) 0.85
Intracranial self-stimulation as a positive reinforcer to study impulsivity in a probability discounting paradigm. J Neurosci Methods (2011) 0.84
Dysbalance of cortical inhibition and excitation in abstinent cocaine-dependent patients. J Psychiatr Res (2011) 0.82
Administration of GABA(B) receptor positive allosteric modulators inhibit the expression of previously established methamphetamine-induced conditioned place preference. Behav Brain Res (2010) 0.81
Repeated mirtazapine nullifies the maintenance of previously established methamphetamine-induced conditioned place preference in rats. Behav Brain Res (2011) 0.80
Baclofen facilitates the extinction of methamphetamine-induced conditioned place preference in rats. Behav Neurosci (2011) 0.80
Cellular distribution of AMPA receptor subunits and mGlu5 following acute and repeated administration of morphine or methamphetamine. J Neurochem (2013) 0.80
Cocaine self-administration enhances excitatory responses of pyramidal neurons in the rat medial prefrontal cortex to human immunodeficiency virus-1 Tat. Eur J Neurosci (2015) 0.80
Context-dependent effects of a single administration of mirtazapine on the expression of methamphetamine-induced conditioned place preference. Front Behav Neurosci (2012) 0.80
Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson's Disease: implications for limbic system and basal ganglia interactions. Brain Struct Funct (2008) 0.80
The atypical antidepressant mirtazapine attenuates expression of morphine-induced place preference and motor sensitization. Brain Res (2012) 0.78
Effect of fendiline on the maintenance and expression of methamphetamine-induced conditioned place preference in Sprague-Dawley rats. Psychopharmacology (Berl) (2013) 0.77
Alterations in responses of ventral pallidal neurons to excitatory amino acids after long-term dopamine depletion. J Pharmacol Exp Ther (2002) 0.77
Methamphetamine self-administration results in persistent dopaminergic pathology: implications for Parkinson's disease risk and reward-seeking. Eur J Neurosci (2014) 0.77
Sensitization by ventral pallidal DAMGO: lack of cross-sensitization to morphine. Neuroreport (2013) 0.77
Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function. Exp Neurol (2004) 0.76
Basal forebrain infusions impair delayed-non-match-to-sample radial arm maze performance. Pharmacol Biochem Behav (2002) 0.76
Serotonin(2C) receptors in the ventral pallidum regulate motor function in rats. Neuroreport (2013) 0.76
Addiction to alcohol and drugs of abuse is a horrific tragedy for affected individuals and their families, and a financial, legal, and social burden for societies. Pharmacol Ther (2005) 0.75